Autres langues C-Rad AB

Actions

CRAD B

SE0002016352

Equipement et technologie médicale avancés

PEA

Marché Fermé - Nasdaq Stockholm 18:00:00 22/09/2026			Varia. 5j.	Varia. 1 janv.
34,00 ^SEK	-1,16 %		-2,86 %	+6,42 %

18/08	La société d'investissement Pamir préparerait son introduction en bourse pour cet automne - Breakit	FW
20/07	Pareto Securities relève l'objectif de cours de C-Rad à 45 couronnes (contre 36), maintient sa recommandation à l'achat	FW

Autres langues

17/07	C-Rad AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
17/07	C RAD : Interim Report Q2'26
17/07	C-RAD's Interim Report Q2’26
15/05	C-Rad, SeeTreat partner to deliver radiotherapy
15/05	C-RAD and SeeTreat partner to deliver personalised radiotherapy for every patient
15/05	C-Rad and Seetreat Partner to Deliver Personalised Radiotherapy for Every Patient
13/05	C-RAD marks its new chapter at ESTRO 2026 with clinician-driven SGRT advances
06/05	C-Rad AB Reports Earnings Results for the First Quarter Ended March 31, 2026
06/05	C Rad Q1 adjusted EBIT SEK 22 mln
06/05	C-RAD's Interim Report Q1’26
10/04	C-RAD publishes its annual report for 2025
12/02	C Rad Q4 order intake decreased 10% to SEK 151 mln
12/02	C-RAD's Year-end report Q4'25
12/02	C-Rad AB (OM:CRAD B) commences an Equity Buyback Plan, under the authorization approved on May 8, 2025.
12/02	C-Rad AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
12/02	C-Rad AB announces Annual dividend, payable on May 15, 2026
29/01	Invitation to presentation of C-RAD’s year-end report and report for the fourth quarter 2025
26/01	Sweden's C-Rad Names New CEO
26/01	C-Rad appoints Tomas Blomquist as CEO
26/01	Tomas Blomquist appointed new CEO of C-RAD
26/01	C-Rad AB Announces CEO Changes
22/10/25	C-RAD has decided to repurchase own class B shares
22/10/25	C-Rad Q3 Ebit up at SEK 21.2 mln
22/10/25	C-Rad CEO to leave
21/10/25	C-Rad AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025